Interview with DSM Biologics President Karen King Jun 20, 2008 Print Email Tweet Karen King, President of DSM Biologics, discusses the implications of the companys recent joint venture with Crucell in this interview with Editor-in-Chief Agnes Shanley at the BIO 2008 Conference.
